BMJ Open Diab Res Care
Diabetic kidney disease in the elderly: prevalence and clinical correlates
In addition to aiding weight loss, semaglutide 2.4 mg also enhances eating regulation, lessens food cravings, and lessens the typical rise in appetite that follows substantial weight loss, all of which support continued weight control [112]
Currently at least five companies have already submitted proposals to manufacture the drug, with some proposals dating as far back as February 2024
In particular, tell your provider if you have a past history of: Type 1 or type 2 diabetes Thyroid cancer Pancreatitis Kidney disease Diabetic retinopathy Depression Suicidal thoughts or behavior Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding
As a result, semaglutide has found a new market as a slimming aid in people without type 2 diabetes, nicknamed the skinny jab